PM01183 Combinado con Olaparib ( Lynparza de Astra Zeneca ) Inician Fase Ib - II en el Tratamiento de Tumores Solidos . Phase Ib/II study to evaluate the efficacy and tolerability of PM01183 in Combination with Olaparib in patients with advanced solid tumors .

Farmacos con los que PM01183 va en Combinación en Ensayos Clinicos :

* Olaparib
* Cisplatin
* Gemcitabine
* Doxorubicin
* Capecitabine
* Paclitaxel
* Bevacizumab

**********************************************************+

Name of Sponsor Andrés Poveda .

*.- Name of organisation providing support Astra Zeneca .
Country Spain .

*.- Name of organisation providing support Pharma Mar .
Country Spain .